EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER Why BHP shares just got a big buy call How to have difficult conversations at work without risking your job Mehdi Hasan Slams Jewish Organizations for Overlooking Young Republicans Going ‘Full Neo-Nazi’ 'A great OLED TV with a few frustrations': I reviewed the LG B6, and it brings some much needed extra brightness to the B-series for HDR punch — but it's a shame a few things hold back it from perfection Galaxy Digital (GLXY): Leopold Aschenbrenner Is Bearish on This Stock SCHX’s 750 stocks hide a 48% concentration risk most dividend investors overlook Ellisons to Bari 60 Minutes The Iran Conflict's Gathering Storm: World Braces for Economic Contagion Jef Raskin, the Visionary Behind the Mac

Zhong Huijuan

Zhong Huijuan

Zhong Huijuan (#178)

Global Rank #178
Country Rank #24
Country China

Zhong Huijuan is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 17 B
  • Pharmaceuticals
  • China
  • F
  • 65 Years

Snapshot

Quick Facts

Global Rank #178
Country Rank #24
Net Worth $16.6B
Previous Worth $16.7B
Worth Change -$0.1B
Country China
Industry Pharmaceuticals
Age 65 Years
Gender F
Worth As Of April 29, 2026
Residence Shanghai, China
Citizenship China
World Billionaires List China Billionaires Pharmaceuticals

Profile Data

Personal Stats

Age 65
Source Of Wealth Pharmaceuticals, Self Made
Residence Shanghai, China
Citizenship China
Marital Status Married
Children 1
Education Bachelor of Science, Jiangsu Normal University; EMBA, Nanjing University
Net Worth Change -$0.1B -0.6% from previous worth
Previous Net Worth $16.7B
Current Net Worth $16.6B

Worth as of April 29, 2026

About Me

Zhong Huijuan is the chairman and CEO of Chinese drugmaker Hansoh Pharmaceutical Group, which produces oncology, psychoactive, antidiabetic and other drugs. Zhong's husband, Sun Piaoyang, is also a billionaire and leads Jiangsu Hengrui Pharmaceuticals, which is dual-listed in Shanghai and Hong Kong. Their daughter, Sun Yuan, is Hansoh's executive director. Headquartered in the Chinese coastal city of Lianyungang, Hansoh went public on the Hong Kong Stock Exchange in 2019. Hansoh has licensed products including weight-loss treatments to global pharmaceutical giants such as Merck in billion-dollar deals, as the firm expands internationally.

Achievements

Forbes List Highlights

A snapshot of the list placements and rankings connected to Zhong Huijuan.

#151
Billionaires (2026)
#16
China's 100 Richest (2025)
#3
World's Richest Self-Made Women (2025)

Wealth Growth

Net Worth Growth Over Time

Tracking Zhong Huijuan's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth
Period Change Worth Movement
Current Net Worth: $16.6B (April 29, 2026)

© Iconic Billionaires